Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

Cancers - Switzerland
doi 10.3390/cancers11091373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Proteomic Investigation of Phosphorylation Sites in Poly(ADP-Ribose) Polymerase-1 and Poly(ADP-Ribose) Glycohydrolase

Journal of Proteome Research
BiochemistryChemistry
2009English

Poly (ADP-ribose) Polymerase Inhibitor, an Effective Radiosensitizer in Lung and Pancreatic Cancers

Oncotarget
Oncology
2017English

The Poly(adp-Ribose) Polymerase Inhibitor Olaparib Induces Up-Regulation of Death Receptors in Primary Acute Myeloid Leukemia Blasts by Nf-Κb Activation

Cancer Letters
Cancer ResearchOncology
2018English

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

Frontiers in Pharmacology
Pharmacology
2020English

Potentiation of Anti-Cancer Agent Cytotoxicity by the Potent Poly(ADP-Ribose) Polymerase Inhibitors NU1025 and NU1064*

British Journal of Cancer
Cancer ResearchOncology
1998English

Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase Inhibits Angiogenesis

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2006English

Family-Wide Analysis of Poly(ADP-Ribose) Polymerase Activity

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Purification and cDNA Cloning of Maize Poly(ADP)-Ribose Polymerase

Plant Physiology
Plant ScienceGeneticsPhysiology
1998English

Targeting Poly(ADP-Ribose) Polymerase Activity for Cancer Therapy

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy